[Experience in using adrenergic blockaders in treating diabetes mellitus].
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000652:urine; D004146:Dioxanes / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D004341:Drug Evaluation; D004837:Epinephrine / Q000652:urine; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010646:Phentolamine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004146:Dioxanes; D011759:Pyrrolidines; D004295:Dihydroxyphenylalanine; D011433:Propranolol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine
Opyt primeneniia adrenoblokatorov pri lechenii bol'nykh sakharnym diabetom.